Tuesday, December 20, 2011

New Clinical Tool Aids Clinicians in Detecting Early Warning Signs of Respiratory Complications

Covidien Announces CE mark for Nellcor™ Respiration Rate Software. Covidien (NYSE: COV), a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced it will label the Covidien Nellcor™ Respiration Rate Version 1.0 Software and the Adult Respiration Rate Sensor with the CE Mark, making the new respiratory monitoring platform available throughout the European Economic Area (EEA).

Get more informaton
www.businesswire.com/news/home/20111219006572/en/Covidien-Announces-CE-Mark-Nellcor%E2%84%A2-Respiration-Rate

No comments:

Post a Comment